{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:59:47Z","timestamp":1782989987300,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.maturitas.2011.06.005","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T14:00:42Z","timestamp":1309960842000},"page":"22-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Vaginal DHEA to treat menopause related atrophy: A review of the evidence"],"prefix":"10.1016","volume":"70","author":[{"given":"Mary","family":"Panjari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (10)","key":"10.1016\/j.maturitas.2011.06.005_bib0005","first-page":"3090","article-title":"Diagnosis and treatment of atrophic vaginitis","volume":"61","author":"Bachmann","year":"2000","journal-title":"American Family Physician"},{"issue":"September (11)","key":"10.1016\/j.maturitas.2011.06.005_bib0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections","volume":"329","author":"Raz","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"May\u2013June (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/gme.0b013e3181948dd0","article-title":"Longitudinal changes in sexual functioning as women transition through menopause: results from the study of women's health across the nation","volume":"16","author":"Avis","year":"2009","journal-title":"Menopause"},{"issue":"August (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1440-0960.2001.00524.x","article-title":"Menopause and the skin","volume":"42","author":"Wines","year":"2001","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1016\/j.maturitas.2011.06.005_bib0025","doi-asserted-by":"crossref","unstructured":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American Menopause Society. Menopause 2007;14(May\u2013June (3) Pt 1):355\u201369; quiz 70-1.","DOI":"10.1097\/gme.0b013e31805170eb"},{"issue":"February (2 Pt 2)","key":"10.1016\/j.maturitas.2011.06.005_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.lpm.2006.12.019","article-title":"Aromatase inhibitors in the adjuvant treatment of early breast cancer Is there still a place for tamoxifen?","volume":"36","author":"Bergerat","year":"2007","journal-title":"Presse Medicale"},{"issue":"May (5)","key":"10.1016\/j.maturitas.2011.06.005_bib0035","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jcem-16-5-580","article-title":"Effect of exogenous corticotropin on the histochemical pattern of the human adrenal cortex and a comparison with the changes during stress","volume":"16","author":"Symington","year":"1956","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"January","key":"10.1016\/j.maturitas.2011.06.005_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/endo-74-1-35","article-title":"Formation of dehydroepiandrosterone during in vivo and in vitro biosynthesis of testosterone by testicular tissue","volume":"74","author":"Hall","year":"1964","journal-title":"Endocrinology"},{"issue":"June","key":"10.1016\/j.maturitas.2011.06.005_bib0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0304-4165(64)90102-3","article-title":"Biosynthesis in vivo of testosterone and delta-4-androstenedione from dehydroepiandrosterone-sodium sulfate by the canine testis and ovary","volume":"86","author":"Aakvaag","year":"1964","journal-title":"Biochimica et Biophysica Acta"},{"issue":"November (8)","key":"10.1016\/j.maturitas.2011.06.005_bib0050","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","article-title":"Neurosteroids: a novel function of the brain","volume":"23","author":"Baulieu","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.maturitas.2011.06.005_bib0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocrine Reviews"},{"issue":"June (24)","key":"10.1016\/j.maturitas.2011.06.005_bib0060","doi-asserted-by":"crossref","first-page":"21379","DOI":"10.1074\/jbc.M200491200","article-title":"Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2 3)","volume":"277","author":"Liu","year":"2002","journal-title":"Journal of Biological Chemistry"},{"issue":"April (4)","key":"10.1016\/j.maturitas.2011.06.005_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.steroids.2004.02.004","article-title":"Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor","volume":"69","author":"Liu","year":"2004","journal-title":"Steroids"},{"issue":"November (11)","key":"10.1016\/j.maturitas.2011.06.005_bib0070","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis \u2013 some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.maturitas.2011.06.005_bib0075","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"October (10)","key":"10.1016\/j.maturitas.2011.06.005_bib0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/jwh.2008.1281","article-title":"Vaginal estrogen therapy for the treatment of atrophic vaginitis","volume":"18","author":"Lynch","year":"2009","journal-title":"Journal of Womens Health (Larchmt)"},{"key":"10.1016\/j.maturitas.2011.06.005_bib0085","doi-asserted-by":"crossref","unstructured":"Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of the North American menopause society. Menopause 2007;14(March\u2013April (2)):168\u201382.","DOI":"10.1097\/gme.0b013e31803167ab"},{"issue":"March (1)","key":"10.1016\/j.maturitas.2011.06.005_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"issue":"May\u2013June (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"issue":"November (5)","key":"10.1016\/j.maturitas.2011.06.005_bib0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/AOG.0b013e31818aa7c3","article-title":"Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet","volume":"112","author":"Simon","year":"2008","journal-title":"Obstetrics and Gynecology"},{"issue":"January (1)","key":"10.1016\/j.maturitas.2011.06.005_bib0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstetrics and Gynecology"},{"issue":"September (2)","key":"10.1016\/j.maturitas.2011.06.005_bib0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the women's health initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"issue":"April (14)","key":"10.1016\/j.maturitas.2011.06.005_bib0115","first-page":"1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"Journal of the American Medical Association"},{"issue":"February (6)","key":"10.1016\/j.maturitas.2011.06.005_bib0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"July (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0125","first-page":"321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"July (7 Suppl. 1)","key":"10.1016\/j.maturitas.2011.06.005_bib0130","first-page":"s1","article-title":"Postmenopausal hormone therapy: an endocrine society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"February (4)","key":"10.1016\/j.maturitas.2011.06.005_bib0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"Beral","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"January\u2013February (1)","key":"10.1016\/j.maturitas.2011.06.005_bib0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"April (4)","key":"10.1016\/j.maturitas.2011.06.005_bib0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Annals of Oncology"},{"issue":"June (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13697137.2010.529967","article-title":"Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients","volume":"14","author":"Pfeiler","year":"2011","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.maturitas.2011.06.005_bib0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study","volume":"16","author":"Witherby","year":"2011","journal-title":"Oncologist"},{"issue":"March (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1743-6109.2009.01667.x","article-title":"A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women","volume":"7","author":"Raghunandan","year":"2010","journal-title":"Journal of Sexual Medicine"},{"issue":"March","key":"10.1016\/j.maturitas.2011.06.005_bib0165","article-title":"DHEA replacement for postmenopausal women","author":"Davis","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"June (2)","key":"10.1016\/j.maturitas.2011.06.005_bib0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.12.017","article-title":"DHEA for postmenopausal women: a review of the evidence","volume":"66","author":"Panjari","year":"2010","journal-title":"Maturitas"},{"issue":"1\u20132","key":"10.1016\/j.maturitas.2011.06.005_bib0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsbmb.2007.09.023","article-title":"Effects of intravaginal dehydroepiandrosterone on vaginal histomorphology, sex steroid receptor expression and cell proliferation in the rat","volume":"109","author":"Berger","year":"2008","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"10","key":"10.1016\/j.maturitas.2011.06.005_bib0180","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jcem.82.10.4306","article-title":"Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women","volume":"82","author":"Labrie","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.maturitas.2011.06.005_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000068953","article-title":"Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia \u2013 a pilot study","volume":"55","author":"Suh-Burgmann","year":"2003","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"2","key":"10.1016\/j.maturitas.2011.06.005_bib0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9378(96)70444-1","article-title":"Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration","volume":"174","author":"Casson","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3\u20135","key":"10.1016\/j.maturitas.2011.06.005_bib0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"111","author":"Labrie","year":"2008","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"September\u2013October (5)","key":"10.1016\/j.maturitas.2011.06.005_bib0200","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/gme.0b013e31819e8930","article-title":"Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"May","key":"10.1016\/j.maturitas.2011.06.005_bib0205","article-title":"Intravaginal dehydroepiandrosterone (Prasterone), a physiological and a highly efficient treatment of vaginal atrophy","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"May","key":"10.1016\/j.maturitas.2011.06.005_bib0210","article-title":"Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women","author":"Labrie","year":"2009","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.maturitas.2011.06.005_bib0215","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590903511547","article-title":"High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy","volume":"26","author":"Labrie","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"April (2)","key":"10.1016\/j.maturitas.2011.06.005_bib0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/13697137.2010.535226","article-title":"Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia","volume":"14","author":"Labrie","year":"2011","journal-title":"Climacteric"},{"issue":"July (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.maturitas.2009.03.020","article-title":"The safety of 52 weeks of oral DHEA therapy for postmenopausal women","volume":"63","author":"Panjari","year":"2009","journal-title":"Maturitas"},{"issue":"March (3)","key":"10.1016\/j.maturitas.2011.06.005_bib0230","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-4731(81)90140-0","article-title":"Inability of human endometrium or myometrium to aromatize androstenedione","volume":"14","author":"Baxendale","year":"1981","journal-title":"Journal of Steroid Biochemistry"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:52:36Z","timestamp":1759913556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211002040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0378512211002040"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.06.005","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal DHEA to treat menopause related atrophy: A review of the evidence","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}